Europe Diabetes Care Drugs Market Size | COVID-19 Impact Analysis | Forecast to 2026
The European diabetes care drugs market is anticipated to grow at a significant CAGR over the forecast period (2020-2026). The UK, Germany, France, Italy, and Spain are some of the major economies contributing to the growth of the market over the forecast period. The key factor that drives the growth of the European diabetes care drugs industry is the presence of a large pool of patients suffering from diabetes and the increased need to serve them the best diabetes care and treatment.
To Request a Sample of our Report on Europe Diabetes
Care Drugs Market: https://www.omrglobal.com/request-sample/europe-diabetes-care-drugs-market
The rising geriatric population, sedentary
lifestyles, unhealthy diets, and increasing levels of physical inactivity are
some of the factors that are likely to increase the risk of diabetes among
people. Hence, this is likely to create the scope for market growth over the
forecast period. Further, the government's support to create awareness among
the people regarding diabetes treatment and care is likely to accelerate the
growth of the market over the forecast period.
In addition, a majority of countries in the region
have implemented a national plan which includes diabetes individually or within
a plan for non-communicable diseases (NCDs). The rising healthcare expenditure
regarding the awareness, diagnosis, and treatment of diabetes is also
contributing to the market growth. The European region approximately spends 9%
of the total global healthcare expenditure and the expenditure on diabetes
largely varies among European countries. Hence, this is likely to support the
growth of the market over the forecast period.
Market Coverage
·
Market number available for – 2019-2026
·
Base year- 2019
·
Forecast period- 2020-2026
·
Segment Covered- By Drug Class
·
Region Covered- Europe
·
Competitive Landscape- Bayer AG, Boehringer Ingelheim International
GmbH, Eli Lilly and Co., Johnson & Johnson Services Inc., Novartis
International AG, Novo Nordisk A/S, and Sanofi SA
(Get 15% Discount on Buying this Report)
A
full Report of Europe Diabetes Care Drugs Market is Available at: https://www.omrglobal.com/industry-reports/europe-diabetes-care-drugs-market
Europe Diabetes Care Drugs Market – Segmentation
By Drug Class
·
Insulins
·
Non-Insulin Injectable Drugs
·
Oral Anti-Diabetic Drugs
·
Combination Drugs
Europe Diabetes Care Drugs Market – Countries Covered
·
Europe
·
UK
·
Germany
·
France
·
Italy
·
Spain
·
Rest of Europe
Company Profiles
·
AstraZeneca Plc
·
Bayer AG
·
Boehringer Ingelheim International GmbH
·
Eli Lilly and Co.
·
Johnson & Johnson Services Inc.
·
Mylan NV
·
Novartis International AG
·
Novo Nordisk A/S
·
Pfizer Inc.
·
Sanofi SA
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment